Aclarion, Inc.
ACONNasdaq
$2.58
↓ -2.3%Jul 17 close · end-of-day
Price
1Y↓ -65.1%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$5.5M
Enterprise Value
-$13.5M
P/E
—
P/S
70.6
P/B
0.3
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$77,879.00
Net Income (TTM)
-$8.0M
Free Cash Flow (TTM)
—
Gross Margin
19.4%
Operating Margin
-10975.2%
Net Margin
-10336.3%
ROE
-41.0%
ROIC
-1039.6%
Debt / Equity
—
Net Cash
$19.0M
Return 1Y
-65.2%
Company profile
Aclarion, Inc. develops software application for magnetic resonance spectroscopy (MRS) in the U.S. It offers NOCISCAN-LS Post-Processor suite, NOCICALC-LS, and NOCIGRAM-LS. The company was formerly known as Nocimed, which changed its name to ACLarion in December 2021.
- CEO
- Brent Ness
- Sector
- Services
- Industry
- Healthcare
- Employees
- 7
- Headquarters
- Colorado
- Website
- aclarion.com
Management & directors
- Bond RyanChief Strategy Officer
- Gould Gregory AChief Financial Officer
- Ness BrentChief Executive Officer
- Thramann Jeffrey JohnExecutive Chairman
Roles derived from SEC Form 4 filings.
Earnings
ACON Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$21,140.00↑ +11.3%
Diluted EPS-$1.34↓ -85.6%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $60,292.00 | $60,444.00 | $75,404.00 | $45,724.00 | $75,730.00 |
| Gross profit | — | -$8,883.00 | -$4,854.00 | -$324.00 | -$38,934.00 | $6,828.00 |
| Operating income | — | -$3.0M | -$5.6M | -$4.9M | -$5.5M | -$7.1M |
| Net income | — | -$5.0M | -$7.1M | -$4.9M | -$7.0M | -$7.2M |
| Diluted EPS | — | -$6.58 | -$19.61 | -$79,782.00 | -$7,478.90 | -$13.61 |
| Operating cash flow | — | -$2.4M | -$4.9M | -$3.6M | -$5.3M | -$7.2M |
| Free cash flow | — | — | — | -$3.6M | -$5.3M | -$7.2M |
| Gross margin | — | -14.7% | -8.0% | -0.4% | -85.2% | 9.0% |
| Operating margin | — | -4897.9% | -9201.2% | -6466.5% | -12057.2% | -9312.5% |
| Net margin | — | -8210.5% | -11694.4% | -6513.4% | -15293.8% | -9551.9% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10,971.00 | $14,407.00 | $10,232.00 | $18,991.00 | $19,319.00 | $18,942.00 | $18,478.00 | $21,140.00 |
| Gross profit | -$12,323.00 | -$6,925.00 | -$10,324.00 | -$4,488.00 | $5,140.00 | $4,386.00 | $1,790.00 | $3,750.00 |
| Operating income | -$1.1M | -$1.3M | -$1.8M | -$1.5M | -$1.7M | -$1.8M | -$2.0M | -$3.0M |
| Net income | -$1.2M | -$1.4M | -$2.0M | -$2.0M | -$1.6M | -$1.7M | -$1.9M | -$2.9M |
| Diluted EPS | -$1,362.83 | -$1,321.49 | -$809.36 | -$9.32 | -$2.75 | -$2.93 | $1.39 | -$1.34 |
| Operating cash flow | -$1.1M | -$1.1M | -$922,862.00 | -$2.5M | -$1.9M | -$1.2M | -$1.6M | -$2.6M |
| Free cash flow | — | -$1.1M | — | — | — | -$1.2M | — | — |
| Gross margin | -112.3% | -48.1% | -100.9% | -23.6% | 26.6% | 23.2% | 9.7% | 17.7% |
| Operating margin | -10350.6% | -8995.3% | -17652.7% | -7856.0% | -8988.6% | -9666.2% | -10785.8% | -14129.3% |
| Net margin | -11285.0% | -9482.7% | -19444.6% | -10728.4% | -8285.9% | -9008.0% | -10223.7% | -13498.5% |
Company news
Jun 10, 2026
Jun 8, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-11 | Bond Ryan· Chief Strategy Officer | Award | 55,000 | $0.00 | $0.00 | filing |
| 2026-06-11 | Sequira Amanda Mae | Award | 20,000 | $0.00 | $0.00 | filing |
| 2026-06-11 | Breidbart Scott | Award | 20,000 | $0.00 | $0.00 | filing |
| 2026-06-11 | Gould Gregory A· Chief Financial Officer | Award | 50,000 | $0.00 | $0.00 | filing |
| 2026-06-11 | Ness Brent· Chief Executive Officer | Award | 100,000 | $0.00 | $0.00 | filing |
| 2026-06-11 | Wesemann William | Award | 20,000 | $0.00 | $0.00 | filing |
| 2026-06-11 | Thramann Jeffrey John· Executive Chairman | Award | 100,000 | $0.00 | $0.00 | filing |
| 2026-06-11 | Neal David K | Award | 20,000 | $0.00 | $0.00 | filing |
| 2026-06-11 | Deitsch Stephen | Award | 20,000 | $0.00 | $0.00 | filing |
| 2026-05-12 | Breidbart Scott | Buy | 5,664 | $3.18 | $18,011.52 | filing |
| 2026-05-11 | Ness Brent· Chief Executive Officer | Buy | 6,289 | $3.18 | $19,999.02 | filing |
| 2026-05-11 | Neal David K | Buy | 2,500 | $3.10 | $7,750.00 | filing |
| 2026-05-06 | Wesemann William | Buy | 1,562 | $3.30 | $5,154.60 | filing |
| 2025-11-26 | Ness Brent· Chief Executive Officer | Buy | 10 | $6.20 | $62.00 | filing |
Latest 14 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.